CereVasc

Congratulations to?Dr. Koji Ebersole and the University of Kansas Medical Center team on their first eShunt? System case in the US Pilot Study of the?CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!

We’re excited to share that CereVasc has been nominated for the Emerging MedTech Company of the Year at the 12th Annual #NEVYs24! Thank you to the New England Venture Capital Association (NEVCA) for recognizing us. We can’t wait to join our fellow innovators in Tech, Tough Tech, Healthcare IT, Life Science, and MedTech and celebrate at the House of Blues on December 5th! #NEVCA #Innovation

Our team is thrilled to be participating in WFITN NEW YORK 2024! Thank you to Dr. Pedro Lylyk of ENERI - Dr. Pedro Lylyk and Dr. Adel Malek of Tufts Medical Center for engaging talks on innovation and the eShunt System. #WFITN24

Excited to share a new publication in the Journal of Molecular Therapy which highlights the eShunt?? Platform as a CNS gene therapy delivery method. Thanks to the teams at UMass Chan Medical School and Tufts Medical Center for your work on this study. "We're very excited about these promising preclinical results, which suggest that the eShunt System delivery approach could provide biopharmaceutical and biotechnology organizations with a minimally invasive method for delivering gene therapies directly to the cortex and brain." #bbb #CNS #drugdelivery #neurovascular #endovascular https://lnkd.in/eeKCGPm7

We are thrilled to announce enrollment of 50 patients in our pilot studies of the eShunt System in patients with NPH! https://lnkd.in/e6F4qW-D #NPH #HAM2024 #hydrocephalus

Thank you to Dr. Pedro Nicolás Lylyk of the ENERI - Dr. Pedro Lylyk team for your fantastic presentation of the One-Year Safety of the eShunt Implant at the 2024 edition of SIMI in Buenos Aires! #SIMI2024

Congratulations to?Dr. David Altschul and the Montefiore Health System team on their first eShunt? System case in the US Pilot Study of the?CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!

Thank you to Dr. Ivan Lylyk of ENERI - Dr. Pedro Lylyk and Dr. Adel Malek for delivering exciting talks on the eShunt System at the European Society for Minimally Invasive Neurological Therapy Annual Meeting. Dr. Lylyk discussed "One Year Safety of the?eShunt? Implant for?the Treatment of Communicating?Hydrocephalus" Dr. Malek discussed "Pilot study CereVasc eShunt system in NPH" #esmint2024

We are excited to announce Breakthrough Device Designation for the eShunt?? System from the FDA! "It is estimated that more than 700,000 individuals in the US suffer from NPH with the vast majority going untreated. Consequently, we have seen strong interest among patients, caregivers, and clinicians in an endovascular treatment option to address this significant health challenge." #endovascular #NPH #hydrocephalus https://lnkd.in/g9vuQT6z

Congratulations to?Dr. Matt Bender at the University of Rochester Medical Center on his first eShunt? System case in the US Pilot Study of the?CereVasc eShunt System in Normal Pressure Hydrocephalus IDE trial!